{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:11:22Z","timestamp":1792030282453,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ijcard.2020.02.015","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T08:26:50Z","timestamp":1580977610000},"page":"87-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases"],"prefix":"10.1016","volume":"307","author":[{"given":"Tsuyoshi","family":"Takada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kotaro","family":"Nochioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruri","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shintaro","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Aoyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahide","family":"Fujihashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shiroto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2020.02.015_bb0005","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1136\/hrt.2003.025270","article-title":"Clinical epidemiology of heart failure","volume":"93","author":"Mosterd","year":"2007","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0010","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1161\/01.CIR.0000039105.49749.6F","article-title":"Framingham Heart Study. Lifetime risk for developing congestive heart failure: the Framingham Heart Study","volume":"106","author":"Lloyd-Jones","year":"2002","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0015","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/ejhf.319","article-title":"Heart failure as a general pandemic in Asia","volume":"17","author":"Shimokawa","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0020","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1161\/01.CIR.0000085166.44904.79","article-title":"Natural history of asymptomatic left ventricular systolic dysfunction in the community","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0025","first-page":"e240","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0030","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.110.979203","article-title":"Cardiac dysfunction and non-cardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community","volume":"124","author":"Lam","year":"2011","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/CIRCHEARTFAILURE.108.768457","article-title":"Health ABC Study. Incident heart failure prediction in the elderly: the health ABC heart failure score","volume":"1","author":"Butler","year":"2008","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0045","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0050","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0735-1097(00)00582-9","article-title":"Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study","volume":"35","author":"Gottdiener","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0055","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1161\/01.CIR.84.4.1625","article-title":"Long-term assessment of the natural history of asymptomatic patients with chronic aortic regurgitation and normal left ventricular systolic function","volume":"84","author":"Bonow","year":"1991","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1253\/circj.CJ-11-0135","article-title":"Trend of westernization of etiology and clinical characteristics of heart failure patients in Japan\u2014first report from the CHART-2 study","volume":"75","author":"Shiba","year":"2011","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0065","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/eurjhf\/hfs001","article-title":"Urinary albumin excretion in heart failure with preserved ejection fraction: an interim analysis of the CHART 2 study","volume":"14","author":"Miura","year":"2012","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ejhf.22","article-title":"Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study","volume":"16","author":"Takada","year":"2014","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0075","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1253\/circj.CJ-15-0514","article-title":"Temporal trends in clinical characteristics, management and prognosis of patients with symptomatic heart failure in Japan \u2014 report from the CHART Studies","volume":"79","author":"Ushigome","year":"2015","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"JASA"},{"key":"10.1016\/j.ijcard.2020.02.015_bb0085","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1467-9574.2011.00496.x","article-title":"How to handle missing data in regression models using information criteria","volume":"65","author":"Rebecca","year":"2011","journal-title":"Stat Neerl."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0090","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v045.i02","article-title":"Multiple imputations with diagnostics (mi) in R: opening windows in the black box","volume":"45","author":"Su","year":"2011","journal-title":"J Statist Software."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0095","unstructured":"Therneau T, Atkinson B, Ripley B. CRAN package rpart. http:\/\/cran.r-project.org\/web\/packages\/rpart\/rpart.pdf. (accessed on September 12, 2019)."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0100","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.amjcard.2007.01.041","article-title":"Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease","volume":"99","author":"Ren","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0105","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1056\/NEJM199209033271003","article-title":"Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions","volume":"327","author":"The SOLVD Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijcard.2020.02.015_bb0110","doi-asserted-by":"crossref","first-page":"6A","DOI":"10.1016\/0735-1097(93)90455-A","article-title":"The epidemiology of heart failure: the Framingham Study","volume":"22","author":"Ho","year":"1993","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7326\/0003-4819-138-1-200301070-00006","article-title":"Framingham Heart Study. Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study","volume":"138","author":"Haider","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0120","first-page":"7","article-title":"Diastolic blood pressure and adverse outcomes in the TOPCAT (treatment of preserved cardiac function heart failure with an aldosterone antagonist) trial","volume":"23","author":"Sandesara","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0125","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(16)31326-5","article-title":"Cardiovascular event rates and mortality according to achieved systolic and diastolic blood pressure in patients with stable coronary artery disease: an international cohort study","volume":"388","author":"Vidal-Petiot","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0130","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijcard.2018.04.031","article-title":"Low diastolic blood pressure and adverse outcomes in heart failure with preserved ejection fraction","volume":"263","author":"Tsujimoto","year":"2018","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2020.02.015_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191736","article-title":"Risk factors for heart failure hospitalizations among patients with atrial fibrillation","volume":"13","author":"Eggimann","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2020.02.015_bb0140","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relation of atrial fibrillation and congestive heart failure and their joint influence on mortality the Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0145","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCEP.114.001938","article-title":"Catheter ablation of atrial fibrillation in patients with left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"7","author":"Anselmino","year":"2014","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0150","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0155","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0165","first-page":"339","article-title":"Risk of cardiovascular disease and all cause mortality among patients with type 2 diabetes prescribed oral antidiabetes drugs: retrospective cohort study using UK general practice research database","volume":"b4731","author":"Tzoulaki","year":"2009","journal-title":"BMJ."},{"key":"10.1016\/j.ijcard.2020.02.015_bb0170","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731934656X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731934656X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T22:41:23Z","timestamp":1588027283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731934656X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":34,"alternative-id":["S016752731934656X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.02.015","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2020.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}